express
purif
character
viruslik
particl
world
j
gastroenterol
abstract
aim
enteroviru
implic
etiolog
agent
respons
recent
outbreak
hand
foot
mouth
diseas
associ
sever
neurolog
diseas
asiapacif
region
assembl
process
hypothes
occur
via
orchestr
proteolyt
process
precursor
viral
proteas
test
hypothesi
construct
recombin
baculovirus
express
express
coexpress
singl
infect
coinfect
result
correct
cleavag
yield
individu
protein
former
approach
yield
higher
vlp
product
cell
structur
protein
selfassembl
cluster
viruslik
particl
vlp
resembl
authent
particl
aggreg
ultracentrifug
purif
dispers
vlp
indistinguish
authent
viru
size
appear
composit
surfac
epitop
determin
sdspage
western
blot
transmiss
electron
microscopi
immunogold
label
data
first
time
suggest
insect
cell
structur
protein
adopt
process
assembl
pathway
similar
polioviru
assembl
preserv
particl
morpholog
composit
suggest
vlp
may
valuabl
vaccin
candid
prevent
epidem
enteroviru
like
polioviru
one
enteroviru
serotyp
belong
picoranvirida
famili
infect
manifest
frequent
hand
foot
mouth
diseas
hfmd
children
year
age
particularli
suscept
sever
form
neurolog
diseas
includ
asept
mening
brainstem
enceph
acut
flaccid
paralysi
indistinguish
poliomyel
neurovirul
first
came
peopl
attent
bulgaria
peopl
die
poliolik
diseas
implic
caus
agent
respons
epidem
central
nervou
system
diseas
occur
new
york
europ
australia
asia
recent
hfmd
outbreak
also
affect
thousand
children
taiwan
japan
singapor
caus
fatal
children
thu
appear
emerg
increasingli
import
neurotrop
enteroviru
upcom
era
poliomyel
erad
howev
effect
antivir
drug
vaccin
avail
yet
possess
posit
singlestrand
rna
genom
consist
singl
open
read
frame
orf
orf
express
larg
polyprotein
coand
posttransl
cleav
region
region
encod
four
structur
protein
region
encod
nonstructur
protein
eg
respons
viru
replic
virul
base
model
deriv
polioviru
proteas
autocatalyt
cleav
nterminu
liber
nascent
polyprotein
proteas
cleav
precursor
tran
three
structur
protein
spontan
assembl
icosahedr
procapsid
order
manner
proceed
seri
intermedi
follow
encapsid
rna
genom
provirion
final
encapsid
step
involv
cleavag
therefor
final
matur
virion
consist
copi
copi
copi
besid
matur
virion
natur
occur
viruslik
particl
vlp
polioviru
discov
vlp
empti
particl
consist
viral
structur
protein
devoid
viral
nucleic
acid
henc
noninfecti
vlp
gener
induc
broad
strong
immun
respons
thank
preserv
mani
essenti
epitop
therefor
vlp
captur
increas
attent
potenti
vaccin
candid
date
numer
vlp
clinic
import
virus
includ
human
immunodefici
vir
us
sar
coronaviru
hepat
delta
viru
express
addit
recombin
polioviru
vlp
produc
use
baculovirusinsect
cell
vaccinia
viru
express
system
particl
produc
via
express
complet
orf
coexpress
individu
protein
coexpress
protein
sinc
polioviru
share
ident
genom
organ
similar
protein
function
hypothes
assembl
occur
way
similar
polioviru
previous
demonstr
format
vlp
coinfect
insect
cell
two
recombin
baculovir
use
express
express
howev
factor
influenc
vlp
yield
investig
vlp
purifi
character
studi
extend
previou
work
construct
new
recombin
baculoviru
simultan
express
new
viru
use
singl
infect
insect
cell
coexpress
synthesi
vlp
yield
vlp
produc
via
singl
infect
coinfect
strategi
compar
final
vlp
purifi
character
spodoptera
frugiperda
insect
cell
cultur
spinner
flask
bellco
use
tnmfh
medium
supplement
mll
fetal
bovin
serum
fb
gibco
brl
describ
elsewher
gene
fragment
code
amplifi
polymeras
chain
reaction
fulllength
cdna
clone
neu
strain
subclon
separ
multipl
clone
site
mc
ii
pfastbac
tm
dual
plasmid
invitrogen
describ
previous
result
plasmid
design
respect
likewis
gene
fragment
clone
mc
polyhedrin
promot
gene
fragment
insert
mc
ii
promot
result
plasmid
carri
two
gene
cassett
design
figur
recombin
baculovirus
subsequ
gener
use
bactobac
system
invitrogen
describ
previous
design
base
gene
encod
recombin
virus
propag
amplifi
store
titer
accord
standard
procedur
confir
express
recombin
infect
cell
harvest
lowspe
centrifug
lyse
incub
lysi
buffer
triton
trisbuff
salin
min
protein
resolv
gl
gel
describ
previous
stain
commassi
blue
western
blot
protein
transfer
onto
nitrocellulos
membran
accord
standard
procedur
biorad
laboratori
transfer
membran
block
gl
nonfat
milk
probe
mous
monoclon
antibodi
mab
secondar
antibodi
g
oat
antimous
igg
conjug
alkalin
phosphatas
kirkegaard
perri
laboratori
membran
develop
bcipnbt
color
develop
reagent
sigma
approxim
ml
cell
cellsml
harvest
postinfect
dpi
centrifug
rmin
min
resuspend
ml
te
buffer
moll
trishcl
moll
edta
ph
cell
suspens
supplement
ml
ho
buffer
moll
tri
moll
nacl
mol
gl
lyse
sonic
min
centrifug
g
rotor
hitachi
min
supernat
pass
filter
remov
debri
ultracentrifug
g
rotor
hitachi
h
pellet
resuspend
te
buffer
sonic
load
onto
discontinu
sucros
gradient
success
express
lane
protein
migrat
faster
also
found
lane
suggest
possibl
degrad
cellular
proteas
nonspecif
degrad
yield
ku
also
note
antibodi
specif
recogn
avail
henc
express
detect
indirectli
observ
whether
cleav
upon
coexpress
protein
lane
depict
either
singl
infect
lane
coinfect
lane
led
complet
cleavag
prove
success
coexpress
function
approach
sinc
reli
cleavag
subsequ
vlp
assembl
delic
control
rel
express
level
cr
ucial
optim
vlp
product
address
issu
cell
coinfect
moi
ratio
singli
infect
moi
order
compar
optim
yield
figur
show
timecours
profil
sucros
dissolv
te
buffer
ultracentrifug
g
rotor
h
milki
white
band
interfac
sucros
collect
layer
top
g
cm
cesium
chlorid
cscl
solut
ultracentrifug
g
rotor
h
band
collect
cscl
gradient
dialyz
phosphatebuff
salin
ph
ultracentrifug
g
h
pellet
resuspend
pure
water
sdspage
western
blot
transmiss
electron
microscopi
tem
analys
puriti
sampl
composit
vlp
quantifi
densitometri
use
scion
imag
sharewar
scion
corpor
vlp
within
insect
cell
visual
transmiss
electron
microscop
hitachi
prior
ultrathin
section
cell
perform
describ
previous
particl
purif
adsorb
onto
mvarcoat
copper
grid
neg
stain
gl
phosphotungst
acid
pta
examin
tem
immunogold
label
purifi
particl
adher
onto
copper
grid
probe
mous
mab
secondari
antibodi
goat
antimous
igg
conjug
nm
gold
particl
sigma
wash
unbound
gold
particl
grid
stain
gl
pta
observ
tem
determin
whether
recombin
success
express
cell
singli
infect
wildtyp
acmnpv
moi
coinfect
moi
moi
cell
harvest
dpi
lyse
western
blot
analysi
shown
figur
mockinfect
wildtyp
acmnpvinfect
cell
express
lane
wherea
cell
express
protein
molecular
mass
correspond
ku
indic
wwwwjgnetcom
product
lane
repres
sampl
harvest
dpi
respect
shown
singl
infect
coinfect
approach
result
similar
express
kinet
except
moi
concentr
rapidli
culmin
dpi
declin
thereaft
virtual
vanish
dpi
concentr
peak
slightli
earlier
compar
mani
protein
whose
maximum
concentr
occur
dpi
probabl
proteolyt
degrad
cellular
proteas
data
shown
figur
figur
reveal
case
coinfect
concentr
increas
moi
provid
total
moi
fix
howev
maximum
yield
obtain
singl
infect
moi
highest
greater
obtain
coinfect
moi
respect
sinc
singl
infect
yield
highest
product
format
vlp
singl
infect
strategi
examin
cell
singli
infect
moi
subject
ultrathin
section
tem
examin
shown
figur
cluster
viruslik
particl
observ
cytoplasm
particl
measur
nm
diamet
appear
icosahedr
thu
resembl
authent
enteroviru
size
appear
vlp
aggreg
observ
cell
infect
alon
data
shown
indic
particl
assembl
product
individu
structur
protein
degrad
precursor
subsequ
vlp
product
perform
infect
insect
cell
moi
particl
releas
infect
cell
purifi
ultracentrifug
analyz
sdspage
figur
western
blot
figur
observ
purifi
sampl
contain
three
major
protein
whose
molecular
mass
correspond
ku
ku
ku
puriti
sampl
greater
figur
molar
concentr
three
protein
determin
scan
densitometri
roughli
equal
agre
notion
molar
ratio
ident
enteroviru
provirion
antibodi
specif
recogn
avail
western
blot
perform
use
antibodi
confirm
ku
protein
purifi
particl
also
subject
tem
examin
figur
show
particl
size
morpholog
similar
particl
observ
vivo
except
purifi
vlp
dispers
immunogold
label
use
antibodi
reveal
gold
particl
surround
distinct
particl
figur
indic
exposur
outer
surfac
data
confirm
infect
success
result
format
vlp
compris
particl
could
purifi
ultracentrifug
near
homogen
purifi
vlp
also
use
standard
measur
specif
yield
vlp
approxim
mg
vlp
express
per
cell
moi
high
express
level
may
contribut
futur
mass
product
downstream
purif
assembl
pathway
definit
identifi
assembl
model
polioviru
suggest
concert
cleavag
proteas
requir
capsid
assembl
studi
recombin
baculovirus
employ
express
simultan
order
mimic
natur
assembl
process
either
singl
infect
coinfect
success
process
figur
demonstr
prove
success
express
function
altern
approach
coexpress
individu
protein
test
vlp
assembl
yet
yield
low
person
commun
comparison
approach
suggest
vlp
synthesi
precursor
favor
rout
agre
assembl
pathway
polioviru
vlp
coinfect
experi
suggest
amount
requir
larger
vlp
assembl
coinfect
moi
yield
consider
larger
amount
moi
figur
intriguingli
observ
singl
infect
superior
coinfect
regard
product
figur
sinc
lack
proper
antibodi
detect
rel
express
level
cell
singli
infect
remain
unclear
howev
sinc
express
driven
polyhedrin
promot
stronger
promot
regul
express
one
may
surmis
differenti
express
aros
name
express
exceed
express
anoth
reason
may
account
higher
product
singl
infect
methodolog
vlpproduc
cell
popul
distribut
result
coinfect
approach
wherebi
cell
coinfect
could
produc
vlp
use
coinfect
methodolog
probabl
cell
infect
one
two
type
virus
number
viru
enter
given
cell
follow
modifi
poisson
distribut
predict
previous
henc
popul
cell
singli
infect
aros
process
vlp
assembl
occur
cell
even
cell
coinfect
virus
number
infect
within
one
cell
might
vari
cell
number
infect
far
exceed
infect
insuffici
express
inadequ
cleavag
could
occur
contrari
cell
infect
consider
outnumb
infect
drought
suppli
could
occur
lead
inadequ
vlp
assembl
heterogen
could
decreas
process
vlp
assembl
mani
cell
contrast
infect
alon
result
process
cell
lead
higher
yield
despit
lower
yield
signific
coinfect
strategi
ignor
offer
new
dimens
manipul
composit
vlp
instanc
cell
may
coinfect
new
recombin
baculoviru
express
deriv
differ
strain
eg
prototyp
brcr
strain
phenotyp
mix
may
allow
incorpor
brcr
strain
vlp
thu
gener
chimer
multival
vlp
broaden
spectrum
protect
addit
higher
express
level
singl
infect
strategi
result
format
vlp
morpholog
indistinguish
authent
virus
within
cell
cluster
viruslik
particl
resembl
observ
human
rhabdomyosarcoma
rd
cell
enterovirusinfect
skelet
muscl
cell
observ
vivo
format
particl
aggreg
previous
report
research
studi
polioviru
vlp
recent
note
cell
infect
footandmouth
diseas
viru
rel
genet
distant
picornaviru
date
biolog
signific
particl
aggreg
remain
explor
resembl
particl
morpholog
aggreg
pattern
vlp
authent
enteroviru
suggest
vlp
adopt
assembl
pathway
insect
cell
way
similar
authent
virus
natur
host
cell
despit
aggreg
within
cell
vlp
could
dispers
solut
purifi
cscl
gradient
ultracentrifug
near
homogen
purifi
vlp
compris
roughli
equal
molar
ratio
result
consist
previou
find
polioviru
provirion
compos
copi
impli
similar
vlp
authent
viru
composit
notabl
insect
cell
appear
undergo
cleavag
matur
process
associ
acquisit
infect
increas
particl
stabil
lack
process
reason
natur
matur
process
take
place
rna
encapsid
yet
express
system
rna
packag
central
caviti
occur
n
n
e
h
e
l
e
f
e
r
p
u
r
f
c
n
h
e
z
e
n
mor
pholog
vlp
appear
indistinguish
polioviru
vlp
importantli
immunogold
label
confirm
presenc
epitop
vlp
surfac
data
suggest
vlp
contain
import
antigen
site
essenti
elicit
immun
respons
particularli
impor
tant
neutral
epitop
dens
cluster
mani
consist
amino
acid
differ
domain
differ
polypeptid
mani
conformationdepend
regard
use
vlp
vaccin
candid
infect
may
particularli
promis
recent
year
vlpbase
vaccin
demonstr
elicit
neutral
antibodi
also
provok
potent
cytotox
helper
tlymphocyt
respons
shown
confer
protect
viru
challeng
anim
model
furthermor
papillomaviruslik
particl
shown
induc
acut
activ
dendrit
cell
vlp
evalu
preclin
studi
potenti
vaccin
includ
jc
viru
human
immunodefici
viru
rotaviru
parvoviru
moreov
humor
mucos
cellular
immun
respons
norwalk
vlp
human
report
vlp
vaccin
human
papillomaviru
enter
phase
ii
clinic
trial
promis
data
present
justifi
develop
vlp
vaccin
sinc
caus
season
morbid
mortal
children
increas
frequenc
recent
year
vaccin
develop
becom
top
prioriti
among
control
strategi
although
vaccin
type
wwwwjgnetcom
inactiv
viru
subunit
vaccin
test
inactiv
viru
elicit
strong
immun
respons
confirm
import
preserv
epitop
conform
howev
assess
safeti
efficaci
inactiv
viru
vaccin
requir
studi
success
demonstr
format
purif
vlp
via
coexpress
reason
product
yield
cell
achiev
thu
offer
attract
altern
inactiv
viru
vaccin
present
immunolog
evalu
imped
due
difficulti
obtain
suffici
amount
pure
vlp
recoveri
yield
vlp
ultracentrifug
low
poor
recoveri
yield
may
attribut
impair
vlp
stabil
empti
capsid
less
stabl
matur
virion
particl
stabil
may
enhanc
addit
stabil
eg
pirodavir
disoxaril
r
bind
pocket
underneath
canyon
particl
feasibl
enhanc
vlp
integr
stabil
evalu
furthermor
develop
effici
chromatographybas
purif
scheme
necessari
process
scaleup
underway
